Bharat Biotech has today announced to increase the capacity to produce 70 million doses of COVAXIN in a year. This goal will be achieved in a phased manner in Hyderabad, and Bengaluru. The company says that capacity expansion in vaccine manufacturing is a long and tedious process. It requires several crores of rupees and many years of investment.
The company said, "Bharat Biotech can expand its capacity to manufacture COVAXIN in a short time." The main reason for this is the availability of specially designed BSL-3 facilities. ”The company said that specialist partners are being sought for vaccine manufacturing in other countries.
Bharat Biotech has partnered with Indian immunologists (IIL) to increase capacity. The process of technology transfer is well underway and IIL has the capability and expertise to manufacture inactivated viral vaccines on a commercial scale and under biosafety control. Bharat Biotech uses a proprietary subsidiary Algel-IMDG, which has now proven to be a safe and effective adjuvant, particularly to stimulate memory T cell responses.
COVAXIN has been approved for emergency use in many countries of the world. With this, negotiations are going on in more than 60 countries. Emergency use has been approved in several other countries including Mexico, the Philippines, Iran, Paraguay, Guatemala, Nicaragua, Guyana, Venezuela, Botswana, Zimbabwe. Talk continues in the United States and many European countries.
After the success of Kalki 2898 AD, Prabhas is away from the limelight, but there is a lot of dis
The 3-match T20I series between India and Sri Lanka is starting from Thursday. The first match be
Union Finance Minister Nirmala Sitharaman presented the Union Budget 2022 for the financial year
India's excellent performance continues in the 2023 Asian Games. On the morning of the 14th day,
On Monday, February 10, the first citizen of the country, President Draupadi Murmu will set foot
Ukraine's war: what new strategy the western countries are making to stop Russia
Three conferences are being held a month after Russia attacks Ukraine. US President Joe Biden arr
Jairam Ramesh and Manish Tewari clashed over Agneepath scheme, a ruckus broke out over an article
Protests were held across the country regarding the Agneepath scheme. At the same time, the oppos
Before Shri Krishna Janmashtami, Shri Krishna's birthplace was decorated with colorful lights. Pr
After the night curfew, weekend lockdown in Maharashtra, now even the 'Break the chain' campaign
The Bharat Jodo Yatra, led by Congress leader Rahul Gandhi, continued on the 13th day of the Maha
